Stockscreener 앱 받기
24.79
1.51%
-0.38
시간 외 거래:
24.79
Sanara Medtech Inc 주식(SMTI)의 최신 뉴스
Sanara MedTech Inc outlines its wound care focus. Longer-term growth story draws investor interest - AD HOC NEWS
Price to sales forward of Sanara MedTech Inc. – BOATS:SMTI - TradingView
Price to book forward of Sanara MedTech Inc. – NASDAQ:SMTI - TradingView
Sanara MedTech, Inc. (SMTI) Investigation: Bronstein, Gewirtz & G - The National Law Review
Sanara MedTech (SMTI) Surges 2.35% as Bulls Test Resistance at $26.08Change of Character - dars.gov.et
How Sanara Medtech Inc. (SMTI) Affects Rotational Strategy Timing - Stock Traders Daily
Sanara MedTech, Inc. Actuals & Estimates (NASDAQ:SMTI) - TradingView
SMTI Forecast — Price Target — Prediction for 2027 - TradingView
Sanara Medtech Inc (SMTI) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Sanara MedTech (SMTI) Stock Gets Fair Value Bump As Analysts Back Wound Care Growth - Yahoo Finance
Sanara Medtech Inc (SMTI) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Sanara Medtech Inc (SMTI) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Sanara Medtech Inc (SMTI) Institutional Confidence - TradingKey
Sanara Medtech Inc (SMTI) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Sanara Medtech Inc (SMTI) Valuation: PE, PB & Fair Value Analysis - TradingKey
SMTI Initiates Coverage by Freedom Broker -- Rating Set to Buy - GuruFocus
Freedom Broker initiates Sanara MedTech stock with buy rating, $35 target - Investing.com UK
(SMTI) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Sanara Medtech Inc (SMTI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Sanara Medtech Inc (SMTI) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Sanara Medtech Inc (SMTI) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Sanara MedTech (SMTI) Rallies 3.68% as Shares Approach Resistance ZoneDollar Neutral Pair - dars.gov.et
Sanara MedTech (SMTI) Slips 3.2% as Stock Tests Key Support LevelsDark Pool Sentiment - newsline.com
Sanara MedTech Inc. (SMTI) Tops Q3 Earnings Estimates - MSN
Sanara MedTech Shareholders Reaffirm Board and Governance Policies - TipRanks
Sanara MedTech (SMTI) investors approve board, auditor and 3-year say-on-pay cycle - Stock Titan
Responsive Playbooks and the SMTI Inflection - Stock Traders Daily
[Form 4] Sanara MedTech Inc. Insider Trading Activity - Stock Titan
Sanara MedTech (SMTI) director receives 4,154 restricted shares, total holdings 26,858 - Stock Titan
Sanara MedTech (SMTI) director awarded 5,308 restricted shares vesting in 2027 - Stock Titan
Sanara MedTech (SMTI) director granted 4,616 restricted stock shares under 2024 plan - Stock Titan
Sanara MedTech Ends Catalyst Advisory Deal, Refocuses Strategy - TipRanks
Sanara Medtech Terminates Services Agreement With Catalyst Effective June 2 - TradingView
Sanara MedTech Ends Advisory Services Agreement With The Catalyst Group Amid Strategy Shift - TradingView
Sanara MedTech (NASDAQ: SMTI) terminates Catalyst advisory agreement - Stock Titan
Sanara MedTech (SMTI) Q1 2026 Earnings Transcript - AOL.com
Sanara MedTech (SMTI) Q1 2026 Earnings Transcript - The Motley Fool
SMTI Stock Price, Quote & Chart | SANARA MEDTECH INC (NASDAQ:SMTI) - ChartMill
Sanara MedTech Inc. (SMTI) Slides as Support Test Looms; Medtech Sector Sentiment WeighsIchimoku Entry - The Legal Advocate
Sanara MedTech (SMTI) Falls 4.2% as Selling Pressure Intensifies Near SupportEarnings Beat Stocks - dars.gov.et
Sanara MedTech (SMTI) Gains 1.75% as Stock Tests Key Resistance LevelGEX Level - newsline.com
Sanara MedTech (SMTI) Q4 2025 Earnings Transcript - AOL.com
Understanding the Setup: (SMTI) and Scalable Risk - Stock Traders Daily
SMTISanara MedTech Inc Stock Price and Quote - Finviz
Sanara MedTech Dips After Swing to Profit - Bez Kabli
Sanara MedTech (SMTI) Edges Lower Amid Modest Trading, Holds Above Key SupportMarket Leader Picks - The Legal Advocate
Bronstein, Gewirtz & Grossman, LLC Encourages Sanara MedTech Inc. (SMTI) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
How The Sanara MedTech (SMTI) Narrative Is Shifting As The US$34 Target Stays Put - Yahoo Finance
Bronstein, Gewirtz & Grossman, LLC Is Investigating Sanara MedTech Inc. (SMTI) And Encourages Shareholders to Connect - ACCESS Newswire
Sanara MedTech (SMTI) Q1 2026 Earnings: EPS $0.05 Beats EstimatesReturn On Equity - The Legal Advocate
Sanara MedTech (SMTI) Q1 2026 Earnings Beat: Revenue $N/A, EPS $0.05Viral Trade Signals - Newser
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanara MedTech, Inc.SMTI - PR Newswire
Pomerantz LLP investigates Sanara MedTech for p... | Pluang – Crypto, Stocks, Gold & Funds - Pluang
Sanara MedTech Inc. (SMTI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Sanara MedTech (SMTI) CEO reports share withholding to cover tax on vested stock - Stock Titan
1.24%
2.13%
자본화:
|
볼륨(24시간):